Literature DB >> 23934048

Differential splicing across immune system lineages.

Ayla Ergun1, Graeme Doran, James C Costello, Henry H Paik, James J Collins, Diane Mathis, Christophe Benoist.   

Abstract

Alternative splicing (AS) allows increased diversity and orthogonal regulation of the transcriptional products of mammalian genomes. To assess the distribution and variation of alternative splicing across cell lineages of the immune system, we comprehensively analyzed RNA sequencing and microarray data generated by the Immunological Genome Project Consortium. AS is pervasive: 60% of genes showed frequent AS isoforms in T or B lymphocytes, with 7,599 previously unreported isoforms. Distinct cell specificity was observed, with differential exon skipping in 5% of genes otherwise coexpressed in both B and T cells. The distribution of isoforms was mostly all or none, suggesting on/off switching as a frequent mode of AS regulation in lymphocytes. From the identification of differential exon use in the microarray data, clustering of exon inclusion/exclusion patterns across all Immunological Genome Project cell types showed that ∼70% of AS exons are distributed along a common pattern linked to lineage differentiation and cell cycling. Other AS events distinguished myeloid from lymphoid cells or affected only a small set of exons without clear lineage specificity (e.g., Ptprc). Computational analysis predicted specific associations between AS exons and splicing regulators, which were verified by detection of the hnRPLL/Ptprc connection.

Entities:  

Mesh:

Year:  2013        PMID: 23934048      PMCID: PMC3761616          DOI: 10.1073/pnas.1311839110

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

Review 2.  CD45: a critical regulator of signaling thresholds in immune cells.

Authors:  Michelle L Hermiston; Zheng Xu; Arthur Weiss
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 3.  Foxp3+ regulatory T cells: differentiation, specification, subphenotypes.

Authors:  Markus Feuerer; Jonathan A Hill; Diane Mathis; Christophe Benoist
Journal:  Nat Immunol       Date:  2009-07       Impact factor: 25.606

4.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

Review 5.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

6.  Analysis and design of RNA sequencing experiments for identifying isoform regulation.

Authors:  Yarden Katz; Eric T Wang; Edoardo M Airoldi; Christopher B Burge
Journal:  Nat Methods       Date:  2010-11-07       Impact factor: 28.547

7.  Memory T cell RNA rearrangement programmed by heterogeneous nuclear ribonucleoprotein hnRNPLL.

Authors:  Zuopeng Wu; Xinying Jia; Laura de la Cruz; Xun-Cheng Su; Bruz Marzolf; Pamela Troisch; Daniel Zak; Adam Hamilton; Belinda Whittle; Di Yu; Daniel Sheahan; Edward Bertram; Alan Aderem; Gottfried Otting; Christopher C Goodnow; Gerard F Hoyne
Journal:  Immunity       Date:  2008-12-19       Impact factor: 31.745

Review 8.  Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn.

Authors:  Nicole M Martinez; Kristen W Lynch
Journal:  Immunol Rev       Date:  2013-05       Impact factor: 12.988

9.  An N-terminal mutation of the Foxp3 transcription factor alleviates arthritis but exacerbates diabetes.

Authors:  Jaime Darce; Dipayan Rudra; Li Li; Junko Nishio; Daniela Cipolletta; Alexander Y Rudensky; Diane Mathis; Christophe Benoist
Journal:  Immunity       Date:  2012-05-10       Impact factor: 31.745

10.  Expression of 24,426 human alternative splicing events and predicted cis regulation in 48 tissues and cell lines.

Authors:  John C Castle; Chaolin Zhang; Jyoti K Shah; Amit V Kulkarni; Auinash Kalsotra; Thomas A Cooper; Jason M Johnson
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

View more
  33 in total

1.  Self-pMHCII complexes are variably expressed in the thymus and periphery independent of mRNA expression but dependent on the activation state of the APCs.

Authors:  Stephanie N Rodriguez; Meizi Jiang; Hideaki Bujo; Paul M Allen
Journal:  Mol Immunol       Date:  2014-10-22       Impact factor: 4.407

2.  FOXP3 interacts with hnRNPF to modulate pre-mRNA alternative splicing.

Authors:  Jianguang Du; Qun Wang; Steven F Ziegler; Baohua Zhou
Journal:  J Biol Chem       Date:  2018-05-17       Impact factor: 5.157

3.  Differential induction of plasma cells by isoforms of human TACI.

Authors:  Yolanda Garcia-Carmona; Montserrat Cols; Adrian T Ting; Lin Radigan; Frank J Yuk; Li Zhang; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2015-01-28       Impact factor: 22.113

Review 4.  Using 'collective omics data' for biomedical research training.

Authors:  Damien Chaussabel; Darawan Rinchai
Journal:  Immunology       Date:  2018-05-30       Impact factor: 7.397

5.  ICAM-1: isoforms and phenotypes.

Authors:  Theresa N Ramos; Daniel C Bullard; Scott R Barnum
Journal:  J Immunol       Date:  2014-05-15       Impact factor: 5.422

6.  An RNAi screen for Aire cofactors reveals a role for Hnrnpl in polymerase release and Aire-activated ectopic transcription.

Authors:  Matthieu Giraud; Nada Jmari; Lina Du; Floriane Carallis; Thomas J F Nieland; Flor M Perez-Campo; Olivier Bensaude; David E Root; Nir Hacohen; Diane Mathis; Christophe Benoist
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-16       Impact factor: 11.205

Review 7.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

Review 8.  Democratizing systems immunology with modular transcriptional repertoire analyses.

Authors:  Damien Chaussabel; Nicole Baldwin
Journal:  Nat Rev Immunol       Date:  2014-04       Impact factor: 53.106

Review 9.  Genomics of alternative splicing: evolution, development and pathophysiology.

Authors:  Eric R Gamazon; Barbara E Stranger
Journal:  Hum Genet       Date:  2014-01-01       Impact factor: 4.132

Review 10.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.